Abstract
Thirty chronically hospitalized, refractory schizophrenic patients were evaluated while on typical neuroleptics and again after 12 weeks of clozapine treatment. Patients demonstrated small but statistically significant reductions in total Brief Psychiatric Rating Scale (BPRS) symptoms, need for seclusion and restraint, and PRN medications, and they frequently were transferred to a less restrictive treatment environment. Neuropsychological test data from a subset of patients suggested improvement on measures of verbal fluency and graphomotor speed, but deterioration on measures of visual memory and executive/frontal ability. Clozapine's different effects on multiple neurotransmitter systems may be responsible for its mixed effects on cognitive abilities. No significant relationships were found between symptom reduction, cognitive improvement, and transfer to a less restrictive environment.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoff, A., Faustman, W., Wieneke, M. et al. The Effects of Clozapine on Symptom Reduction, Neurocognitive Function, and Clinical Management in Treatment-Refractory State Hospital Schizophrenic Inpatients. Neuropsychopharmacol 15, 361–369 (1996). https://doi.org/10.1016/0893-133X(95)00242-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/0893-133X(95)00242-6
Keywords
This article is cited by
-
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Schizophrenia (2023)
-
Reversal of Subchronic PCP-Induced Deficits in Attentional Set Shifting in Rats by Sertindole and a 5-HT6 Receptor Antagonist: Comparison Among Antipsychotics
Neuropsychopharmacology (2008)
-
Reversal of PCP-induced learning and memory deficits in the Morris’ water maze by sertindole and other antipsychotics
Psychopharmacology (2007)
-
Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task
Psychopharmacology (2007)
-
The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine
Psychopharmacology (2006)